Tech Company Financing Transactions

Immunomic Therapeutics Funding Round

Immunomic Therapeutics secured a $3 million venture capital round on 7/17/2013. Investors included private investors.

Transaction Overview

Announced On
7/17/2013
Transaction Type
Debt
Amount
$3,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company will use the proceeds to advance a cedar-pollen allergy vaccine and a new peanut-allergy vaccine toward commercialization.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
15010 Broschart Rd. 250
Hershey, MD 20850
USA
Email Address
Overview
Immunomic Therapeutics, Inc. is developing next generation vaccines focusing on allergy immunotherapy. The Company's first vaccine will be for Japanese Red Cedar, JRC-LAMP-vax.
Profile
Immunomic Therapeutics LinkedIn Company Profile
Social Media
Immunomic Therapeutics Company Twitter Account
Company News
Immunomic Therapeutics News
Facebook
Immunomic Therapeutics on Facebook
YouTube
Immunomic Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
William Hearl
  William Hearl LinkedIn Profile  William Hearl Twitter Account  William Hearl News  William Hearl on Facebook
Chief Financial Officer
Eric Winzer
  Eric Winzer LinkedIn Profile  Eric Winzer Twitter Account  Eric Winzer News  Eric Winzer on Facebook
Chief Scientific Officer
Teri Heiland
  Teri Heiland LinkedIn Profile  Teri Heiland Twitter Account  Teri Heiland News  Teri Heiland on Facebook
Vice President
Andrew Eisen
  Andrew Eisen LinkedIn Profile  Andrew Eisen Twitter Account  Andrew Eisen News  Andrew Eisen on Facebook
VP - Bus. Development
Sia Anagnostou
  Sia Anagnostou LinkedIn Profile  Sia Anagnostou Twitter Account  Sia Anagnostou News  Sia Anagnostou on Facebook
VP - Operations
Timothy Coleman
  Timothy Coleman LinkedIn Profile  Timothy Coleman Twitter Account  Timothy Coleman News  Timothy Coleman on Facebook
VP - Regulatory Affairs
Louise Peltier
  Louise Peltier LinkedIn Profile  Louise Peltier Twitter Account  Louise Peltier News  Louise Peltier on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/17/2013: Markerly venture capital transaction
Next: 7/17/2013: Grovo venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary